PetMed Express Inc
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional suppleme… Read more
PetMed Express Inc (PETS) - Net Assets
Latest net assets as of December 2025: $32.77 Million USD
Based on the latest financial reports, PetMed Express Inc (PETS) has net assets worth $32.77 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($87.97 Million) and total liabilities ($55.20 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $32.77 Million |
| % of Total Assets | 37.25% |
| Annual Growth Rate | 18.54% |
| 5-Year Change | -25.6% |
| 10-Year Change | 28.23% |
| Growth Volatility | 62.94 |
PetMed Express Inc - Net Assets Trend (2000–2024)
This chart illustrates how PetMed Express Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PetMed Express Inc (2000–2024)
The table below shows the annual net assets of PetMed Express Inc from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-03-31 | $96.73 Million | -12.04% |
| 2023-03-31 | $109.97 Million | -22.66% |
| 2022-03-31 | $142.19 Million | +0.64% |
| 2021-03-31 | $141.28 Million | +8.67% |
| 2020-03-31 | $130.01 Million | -3.47% |
| 2019-03-31 | $134.68 Million | +16.37% |
| 2018-03-31 | $115.73 Million | +23.95% |
| 2017-03-31 | $93.37 Million | +12.23% |
| 2016-03-31 | $83.19 Million | +10.29% |
| 2015-03-31 | $75.44 Million | +7.43% |
| 2014-03-31 | $70.22 Million | +9.69% |
| 2013-03-31 | $64.01 Million | -21.15% |
| 2012-03-31 | $81.18 Million | -16.31% |
| 2011-03-31 | $97.00 Million | +0.15% |
| 2010-03-31 | $96.86 Million | +29.20% |
| 2009-03-31 | $74.97 Million | +11.84% |
| 2008-03-31 | $67.03 Million | +24.45% |
| 2007-03-31 | $53.86 Million | +43.10% |
| 2006-03-31 | $37.64 Million | +55.43% |
| 2005-03-31 | $24.22 Million | +73.05% |
| 2004-03-31 | $13.99 Million | +150.23% |
| 2003-03-31 | $5.59 Million | +253.36% |
| 2002-03-31 | $1.58 Million | +109.00% |
| 2001-03-31 | $757.29K | -53.56% |
| 2000-03-31 | $1.63 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to PetMed Express Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 7452514900.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $71.56 Million | 73.97% |
| Common Stock | $21.00K | 0.02% |
| Other Components | $25.16 Million | 26.01% |
| Total Equity | $96.73 Million | 100.00% |
PetMed Express Inc Competitors by Market Cap
The table below lists competitors of PetMed Express Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LEBON NOM. O.N.
F:88J
|
$34.59 Million |
|
Complex Micro Interconnection Co. Ltd.
TW:6835
|
$34.59 Million |
|
Credit Clear Ltd
AU:CCR
|
$34.60 Million |
|
YAS Co., Ltd.
KQ:255440
|
$34.60 Million |
|
BranchOut Food Inc. Common Stock
NASDAQ:BOF
|
$34.58 Million |
|
Business Online PCL
BK:BOL
|
$34.57 Million |
|
CHOROKBAEM COMPANY Co. Ltd
KQ:052300
|
$34.55 Million |
|
PharmGen Science Inc
KO:004720
|
$34.55 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PetMed Express Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 109,966,000 to 96,731,000, a change of -13,235,000 (-12.0%).
- Net loss of 7,464,000 reduced equity.
- Dividend payments of 12,437,000 reduced retained earnings.
- Other factors increased equity by 6,666,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.46 Million | -7.72% |
| Dividends Paid | $12.44 Million | -12.86% |
| Other Changes | $6.67 Million | +6.89% |
| Total Change | $- | -12.04% |
Book Value vs Market Value Analysis
This analysis compares PetMed Express Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.53x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 9.73x to 0.53x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-03-31 | $0.26 | $2.49 | x |
| 2001-03-31 | $0.08 | $2.49 | x |
| 2002-03-31 | $0.08 | $2.49 | x |
| 2003-03-31 | $0.27 | $2.49 | x |
| 2004-03-31 | $0.59 | $2.49 | x |
| 2005-03-31 | $1.02 | $2.49 | x |
| 2006-03-31 | $1.55 | $2.49 | x |
| 2007-03-31 | $2.22 | $2.49 | x |
| 2008-03-31 | $2.76 | $2.49 | x |
| 2009-03-31 | $3.19 | $2.49 | x |
| 2010-03-31 | $4.26 | $2.49 | x |
| 2011-03-31 | $4.28 | $2.49 | x |
| 2012-03-31 | $3.92 | $2.49 | x |
| 2013-03-31 | $3.19 | $2.49 | x |
| 2014-03-31 | $3.50 | $2.49 | x |
| 2015-03-31 | $3.75 | $2.49 | x |
| 2016-03-31 | $4.11 | $2.49 | x |
| 2017-03-31 | $4.58 | $2.49 | x |
| 2018-03-31 | $5.66 | $2.49 | x |
| 2019-03-31 | $6.57 | $2.49 | x |
| 2020-03-31 | $6.48 | $2.49 | x |
| 2021-03-31 | $7.02 | $2.49 | x |
| 2022-03-31 | $6.98 | $2.49 | x |
| 2023-03-31 | $5.41 | $2.49 | x |
| 2024-03-31 | $4.74 | $2.49 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PetMed Express Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -7.72%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.72%
- • Asset Turnover: 1.61x
- • Equity Multiplier: 1.76x
- Recent ROE (-7.72%) is below the historical average (4.98%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | -110.02% | -12.22% | 2.32x | 3.88x | $-1.96 Million |
| 2001 | -373.27% | -28.25% | 2.22x | 5.95x | $-2.90 Million |
| 2002 | 52.15% | 2.58% | 6.88x | 2.94x | $667.14K |
| 2003 | 58.25% | 5.93% | 6.09x | 1.61x | $2.70 Million |
| 2004 | 41.54% | 6.19% | 5.09x | 1.32x | $4.41 Million |
| 2005 | 33.08% | 7.39% | 3.85x | 1.16x | $5.59 Million |
| 2006 | 32.05% | 8.77% | 3.23x | 1.13x | $8.30 Million |
| 2007 | 26.81% | 8.90% | 2.65x | 1.14x | $9.06 Million |
| 2008 | 29.87% | 10.63% | 2.56x | 1.10x | $13.32 Million |
| 2009 | 30.65% | 10.47% | 2.68x | 1.09x | $15.48 Million |
| 2010 | 26.85% | 10.91% | 2.29x | 1.08x | $16.32 Million |
| 2011 | 21.52% | 9.01% | 2.18x | 1.10x | $11.17 Million |
| 2012 | 20.52% | 6.99% | 2.62x | 1.12x | $8.54 Million |
| 2013 | 26.81% | 7.53% | 3.11x | 1.14x | $10.76 Million |
| 2014 | 25.59% | 7.70% | 2.98x | 1.12x | $10.95 Million |
| 2015 | 23.14% | 7.61% | 2.77x | 1.10x | $9.91 Million |
| 2016 | 24.72% | 8.76% | 2.60x | 1.09x | $12.25 Million |
| 2017 | 25.51% | 9.56% | 2.21x | 1.21x | $14.48 Million |
| 2018 | 32.22% | 13.62% | 2.03x | 1.17x | $25.71 Million |
| 2019 | 28.02% | 13.32% | 1.84x | 1.15x | $24.27 Million |
| 2020 | 19.88% | 9.10% | 1.83x | 1.19x | $12.85 Million |
| 2021 | 16.93% | 7.88% | 1.62x | 1.33x | $9.79 Million |
| 2022 | 14.84% | 7.72% | 1.55x | 1.24x | $6.88 Million |
| 2023 | 4.67% | 2.00% | 1.51x | 1.55x | $-5.86 Million |
| 2024 | -7.72% | -2.72% | 1.61x | 1.76x | $-17.14 Million |
Industry Comparison
This section compares PetMed Express Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $239,198,060
- Average return on equity (ROE) among peers: -6.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PetMed Express Inc (PETS) | $32.77 Million | -110.02% | 1.68x | $34.58 Million |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.74 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.98 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $791.20 |